Although the majority of the studies on the prognostic and predictive role of TP53 status in human cancers distinguish between patients harboring WT versus mutant proteins, some evidence favors a categorization of TP53 mutations since different mutant P53 proteins can have different biologic effects. This evidence concerns the gene TP53 and cancer.